NIFTY 50
22,904.45 (-1.49%)
NIFTY IT
33,511.40 (-3.58%)
NIFTY AUTO
20,593.15 (-2.70%)
NIFTY FINANCIAL SERVICES
24,774.30 (0.20%)
NIFTY BANK
51,502.70 (-0.18%)
NIFTY REALTY
823.05 (-3.60%)
NIFTY ENERGY
32,308.90 (-3.73%)
NIFTY METAL
8,414.45 (-6.56%)
NIFTY FMCG
53,830.70 (0.04%)
NIFTY HEALTH CARE
13,426.80 (-3.05%)
NIFTY PHARMA
20,560.00 (-4.03%)
NIFTY MEDIA
20,560.00 (-4.03%)
Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Laurus Labs Ltd

  • Share Price :
  • 574.45
  • -46.20(-7.44%)
Laurus Labs Ltd (NSE)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 3Y
  • 5Y

-46.20(-7.44%)

574.45
Open
620.65		 Prev. Close
620.65
Price
574.45		 Value
41,855.43
52 week high
646.20		 52 week low
385.45
Today’s high
621.80		 Today’s low
561.50
Volume
7,286,175		 ISIN
INE947Q01028

Laurus Labs Ltd Ltd

  • Sector : Pharmaceuticals
  • MCAP : 33452.53 Crore
Laurus Labs is a science-led, fully integrated pharmaceutical and biotechnology manufacturing company with a leadership position in generic active pharmaceutical ingredients (APIs) in selected high-growth therapeutic areas of anti-retrovirals (ARVs), Hepatitis C and Oncology. The company also manufactures APIs in oncology and other therapeutic areas, such as anti-asthma, ophthalmology, antidiabetics, cardiovascular, proton pump inhibitors (PPIs) amongst others. The company currently operates 4 manufacturing facilities in Visakhapatnam, Andhra Pradesh. Three of these facilities manufacture APIs and ingredients, while the fourth facility produces Finished Dosage Formulations (FDFs) and one API. The company's strategic and earl
More

Laurus Labs Ltd Share Price History

Date Open Close Low High
04-Apr-2025 620.65 574.45 561.50 621.80
03-Apr-2025 620.15 620.65 611.15 638.90
02-Apr-2025 604.00 609.05 594.50 610.85
01-Apr-2025 611.00 598.90 594.95 617.80
28-Mar-2025 619.90 613.40 606.70 626.65

Share Holding

Total Foreign

Total Institutions

Total Govt Holding

Total Non Promoter Corporate Holding

Total Promoters

Total Public & others

Corporate Actions

Announcement Date Ex Dividend Date Dividends (%) Dividend Type
24-Oct-2024 06-Nov-2024 20 Interim
25-Apr-2024 08-May-2024 20 Interim 2
20-Oct-2023 02-Nov-2023 20 Interim
27-Apr-2023 10-May-2023 60 Interim 2
21-Oct-2022 03-Nov-2022 40 Interim

Peer Comparison

Company Name LTP Market Cap Prev. Close Change (%) 52 Week
High-Low (₹) 		Todays
High-Low (₹) 		PE (TTM) PB (₹) Dividend Yield (%)
Sun Pharmaceuti... 1,709.35 410,130.32 1,770.00 -3.43 1,960.35 - 1,377.20 1,778.85 - 1,658.05 130.19 17.38 0.79
Cipla Ltd 1,415.25 114,298.01 1,495.70 -5.38 1,702.05 - 1,317.25 1,495.70 - 1,390.05 24.27 3.92 0.92
Mankind Pharma ... 2,451.20 101,131.25 2,427.70 0.97 3,054.80 - 1,901.05 2,463.45 - 2,405.00 50.09 7.33 0.00
Dr Reddys Labor... 1,109.95 92,620.37 1,151.45 -3.60 1,421.49 - 1,076.20 1,157.45 - 1,076.20 17.86 3.44 0.72
Lupin Ltd 1,971.05 89,991.25 2,095.70 -5.95 2,402.90 - 1,493.30 2,089.95 - 1,916.00 29.35 4.09 0.41
Zydus Lifescien... 866.90 87,230.42 901.90 -3.88 1,324.30 - 834.50 905.95 - 834.50 19.97 4.87 0.35
Aurobindo Pharm... 1,105.35 64,766.72 1,176.35 -6.04 1,592.00 - 1,031.05 1,179.45 - 1,050.10 33.77 3.29 0.41
Alkem Laborator... 4,828.70 57,734.35 4,971.55 -2.87 6,439.90 - 4,407.05 4,929.25 - 4,738.55 24.77 4.90 0.83
Glenmark Pharma... 1,499.85 42,323.99 1,545.25 -2.94 1,830.95 - 985.20 1,545.25 - 1,469.00 6.96 1.77 0.17
Biocon Ltd 327.80 39,355.67 345.75 -5.19 404.70 - 259.85 343.20 - 321.30 65.46 3.62 0.15
Ipca Laboratori... 1,399.25 35,499.56 1,497.60 -6.57 1,755.90 - 1,052.00 1,491.75 - 1,358.50 45.50 5.27 0.29
Piramal Pharma ... 222.32 29,474.03 230.11 -3.39 307.90 - 132.40 230.24 - 217.00 42.94 4.20 0.05

Company News

More
About INVES 21
Insights

S A Artha Securities Private Limited,
CIN: U65900TG2022PTC167512.
Registered Office: Flat No.202A, La Paloma Caves, Road No 12, Banjara Hills, Hyderabad, Telangana- 500034,
Correspondence Office: Plot No: 27, Jayabheri Enclave, 2nd Floor, Sri Vishnu Elite Building, Gachibowli, Hyderabad, Telangana- 500032.
Tel No: 040-48444546.
SEBI Reg. No: NSE: INZ000316838 | BSE Member Code: 6902 | SEBI Reg. No: Research Analyst: INH000016667 | Mutual Fund Distributor: AMFI Reg. No ARN- 279815
SEBI Reg. No: Depository Participant (NSDL): IN-DP-776-2024 | Member: NSE - TM Code-90369.

Details of Client Bank Account
For any query / feedback / clarification, email at info@inves21.com

In case of grievance for any of the services rendered by S A Artha Securities Private Limited, please write to grievance@inves21.com (for NSE). Please ensure that you carefully read the Risk Disclosure Document as prescribed by SEBI, our Terms & Conditions, and Privacy Policy. Compliance Officer: Mr. Raju N H N, E-mail address: compliance@inves21.com. To lodge your complaints using SEBI SCORES, Click here.

Procedure to file a complaint on SEBI SCORES:
- Register on SCORES portal.
- Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID.
- Benefits: Effective Communication, Speedy redressal of grievances.

Disclaimer: Investments in the securities market are subject to market risks; read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit.

Attention investors:

  • Stock brokers can accept securities as margins from clients only by way of pledge in the depository system w. e. f. September 01, 2020   
  • Update your e-mail and phone number with your stock broker/ depository participant and receive OTP directly from the depository on your e-mail and / or mobile number to create a pledge.
  • Check your securities/ MF / bonds in the consolidated account statement issued by NSDL/CDSL every month.

Note: To prevent unauthorized transactions in your account. Update your mobile number/email IDs with your stock brokers. Receive information on your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets. Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund, etc.), you need not undergo the same process again when you approach an intermediary. “Dear investor, if you are subscribing to an IPO, there is no need to issue a cheque. Please write the bank account number and sign the IPO application form to authorize your bank to make payment in case of allotment. In case of non-allotment, the funds will remain in your bank account.
S A Artha Securities Private Limited is a distributor of Mutual funds. Mutual fund investments are subject to market risks, and all disputes with respect to the distribution activity would not have access to the Exchange investor redressal forum or Arbitration mechanism. Please read all scheme-related documents carefully before investing. The past performance of the schemes is neither an indicator nor a guarantee of future performance.
Download client registration documents (Rights & Obligations, Risk Disclosure Document, Do's & Don'ts) in vernacular language: NSE

Kindly read the Advisory Guidelines of NSE for investors as prescribed by the exchange with reference to their circular dated 27th August 2021 regarding investor awareness and safeguarding client’s assets.

  • Copyright © 2024   INVES 21
  • Designed, developed and Content Provide by CMOTS Infotech (ISO 9001:2015 certified)